Screener
Krystal Biotech, Inc. KRYS Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s invested capital?
- Krystal Biotech, Inc. (KRYS) reported invested capital of $784.53M in Q1 2026.
- How has Krystal Biotech, Inc.'s invested capital changed year-over-year?
- Krystal Biotech, Inc.'s invested capital increased by 14.4% year-over-year, from $685.57M to $784.53M.
- What is the long-term trend for Krystal Biotech, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s invested capital has grown at a 92.4% compound annual growth rate (CAGR), from $27.76M to $732.6M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Krystal Biotech, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude